Tirzepatide, also known as LY3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This peptide is primarily developed for research related to type 2 diabetes and weight management studies. It demonstrates significant efficacy in glucose control and weight reduction compared to selective GLP-1 receptor agonists.
The molecular structure of Tirzepatide includes a PEG modification on the lys side chain, enhancing water solubility and functional performance. It mimics natural GIP actions at receptors and has shown promising results in clinical research for hyperglycemia reduction and weight loss in overweight subjects.
Research indicates that Tirzepatide aids in substantial weight reduction, with clinical trials reporting average losses of 15% to 20.9% over 72 weeks depending on dosage. It is intended for once-weekly administration in research settings to study its effects on metabolic conditions.
This product is supplied as a white powder, packaged in vials of 10mg each, with options for 10mg, 20mg, 30mg, and 35mg sizes. Each order includes 10 vials per box, and the minimum order quantity is 10 vials. It is crucial to store Tirzepatide in a cold, dry, and dark place to maintain stability, avoiding repeated freezing-thawing cycles and light exposure.
For researchers looking to buy Tirzepatide, this product offers high purity and consistent quality, ideal for laboratory experiments and developmental studies. It is not intended for personal use and should be handled by qualified professionals in controlled environments.